Trump psychedelics order largely symbolic, analysts say
Executive order to speed access to psychedelic treatments likely to have limited legal impact despite high-profile push
The https://www.theguardian.com/us-news/trump-administration">Trump administration issued an executive https://www.whitehouse.gov/presidential-actions/2026/04/accelerating-medical-treatments-for-serious-mental-illness/">order earlier this month to accelerate access to psychedelic medication for people with “serious mental illnesses,” but experts say the order is more likely to make a difference symbolically than legally.
“Policymakers and the medical field have long struggled to address the burden of suicide and serious mental illness rates in America,” the order reads, noting that some people do not respond to available treatments.
https://www.theguardian.com/us-news/2026/apr/24/trump-psychedelic-medication-order">Continue reading...- U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive CTV News —
- US FDA plans ultra-fast review of 3 psychedelic drugs after Trump directive South China Morning Post —
- FDA grants quick review for 3 psychedelic drug trials NBC News —
- FDA fast-tracks psychedelic drug research following Trump executive order CNBC —
- FDA plans fast review of 3 psychedelic drugs following Trump directive Boston Globe —